Swixx BioPharma
PrivateLast Round
Buyout/LBO
Dec 15, 2025
Est. Valuation
$1.76B
Total Funding Raised
$78.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Swixx BioPharma operates in Healthcare & Life Sciences and is based in Baar. Its latest recorded funding round was a Private Equity round in May 2021.
Swixx BioPharma is a healthcare services company that operates as a commercialization platform for biopharmaceutical, OTC, and medical device companies in markets where they choose not to have a direct presence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swixx BioPharma Comparables
Compare Swixx BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GENESIS Pharma | 84% | |
| SALUS, Ljubljana, d.d. | 82% | |
| EVERSANA | 77% |
For institutional investors. Book with your work email.
Swixx BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Dec 15, 2025 | ||||
| Private Equity | May 20, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Swixx BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Buyout/LBO |
| HBM Healthcare Investments | Seed, Private Equity, Buyout/LBO |
| Mérieux Equity Partners | Buyout/LBO, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 37% MoM.
- Dec 15, 2025
Closed at $1.76B post-money valuation with SK Capital Partners leading.
For institutional investors. Book with your work email.
Swixx BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Swixx BioPharma's valuation, stock price, and market status.
Is Swixx BioPharma a public or private company?
Swixx BioPharma is a private company.
What is the current stock price of Swixx BioPharma?
Swixx BioPharma is a private company, so its shares have no public market price. Caplight tracks Swixx BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Swixx BioPharma worth (valuation)?
Swixx BioPharma's valuation is estimated at $1.8B based on funding round data.
Can I buy Swixx BioPharma stock?
Swixx BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Swixx BioPharma's last funding round?
Swixx BioPharma's most recent funding round was Buyout/LBO on December 15, 2025.
Who are the main investors in Swixx BioPharma?
Key investors in Swixx BioPharma include Mérieux Equity Partners.
Will Swixx BioPharma IPO soon?
No public IPO plans have been announced for Swixx BioPharma.
How can I track Swixx BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in Swixx BioPharma's shares on secondary markets.